Is TB-500 Legal in South Carolina? How to Access It Legally

HealthRX.com

No list shows this peptide can be compounded in South Carolina

Print or save as PDF

See the public record for TB-500

  • Drug / TB-500, a synthetic 7-amino-acid fragment of thymosin beta-4 [1]
  • FDA approval / None [1]
  • List for state-licensed pharmacies and physicians / Not listed [2][4]
  • List for outsourcing facilities / Not listed [3]
  • HHS draft policy / Enforcement discretion for TB-500 acetate by injection if conditions are met; not binding, not an approval [6][7]
  • Sport / Prohibited at all times by WADA [8][9]

What TB-500 is, and is it approved?

TB-500 is a synthetic, N-acetylated 7-amino-acid fragment of thymosin beta-4 - residues 17 to 23 of the 43-amino-acid protein - not the full protein [1]. It is not an FDA-approved drug: FDA's July 2026 review found no USP or National Formulary monograph, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK, Belgium, Ireland, France, Norway, Germany, Spain or Italy or authorized by the European Medicines Agency [1]. FDA found no published study in which a person received TB-500 [1].

Is it on FDA's compounding lists?

State-licensed pharmacies and physicians may only compound with bulk substances that meet a USP or National Formulary monograph, are components of an FDA-approved drug, or appear on FDA's bulks list [4]. FDA found none of the first two for TB-500, and it is not on the bulks list [1].

TB-500 appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians [2][4] and is absent from the separate list for outsourcing facilities [3]. FDA's safety-risk page places 'Thymosin beta-4, fragment (LKKTETQ), also known as TB-500' in the table of substances nominated but withdrawn; removal from category 2 was not a finding that it is safe [10].

FDA reports that TB-500 is sold online as 'research use only' injectable powder, and that it found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].

Questions worth asking

Choose the questions you want to keep

What changed in 2026

FDA's Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding TB-500 to the list, against FDA staff's recommendation; that advice is non-binding, and adding a substance takes formal rulemaking [11][6].

HHS filed a draft enforcement-discretion policy naming TB-500 among six peptides [6][7]. It covers TB-500 acetate by subcutaneous or intramuscular injection and says HHS does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it when conditions are met, such as a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis [6][7]. The notice states it 'does not establish any rights for any person and is not binding on HHS or the public' [6].

What does the South Carolina Medical Board's page show?

The South Carolina Board of Medical Examiners licenses and disciplines physicians and lists a notice titled 'Notice Concerning the Prescribing of Research-Grade Peptides and FDA-Ineligible Peptides' [5]. The Board's page shows only that title, not what the notice requires for TB-500 [5]. Compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before marketing [6].

Human data and sport

There is no approved dose and no human dosing study of TB-500 [1]. An FDA adverse-event database search through March 26, 2025 retrieved no TB-500 reports, and FDA found no published case reports, so safety in humans is unknown [1]. WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times, on both the 2026 and 2027 Lists [8][9].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. What does the South Carolina Board's page show about the research-grade peptide notice?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is TB-500 legal in South Carolina?
Nothing in FDA's lists or on the South Carolina Board of Medical Examiners' page establishes that it is. TB-500 is not FDA-approved and is not on FDA's compounding bulks lists [1][2][3][4]. The Board lists a notice on prescribing research-grade and FDA-ineligible peptides, but its page shows only the title [5]. HHS's draft policy on TB-500 acetate injections is not binding and is not an approval [6][7].
What does the July 2026 advisory committee vote mean?
The Pharmacy Compounding Advisory Committee voted in favor of adding TB-500 to the list on July 23, 2026, against FDA staff's recommendation [11][6]. The recommendation is advice only; a substance is added through formal rulemaking, and TB-500 is not on the list [11][6].
Is TB-500 the same as thymosin beta-4?
No. TB-500 is a synthetic, N-acetylated 7-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4 [1]. Studies of full-length thymosin beta-4, including eye-drop and intravenous recombinant products, do not show that TB-500 works or is safe [1].
Is TB-500 banned in sport?
Yes. WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times, in and out of competition [8], and it remains on the 2027 List [9].
Show all 11 referencesHide references
Evidence overview for Is TB-500 Legal in South Carolina? How to Access It Legally